Canada Research Chair in Trained Immunity
Maziar Divangahi appointed a new Canada Research Chair in Trained Immunity
Maziar Divangahi
View his faculty profile here: Maziar Divangahi, PhD
Professor, Department of Medicine, McGill University
Associate Director, Meakins-Christie Laboratories
Research Theme: Host defense against pulmonary pathogens; regulation of death program in macrophages
Keywords: innate and adaptive immunity • influenza virus • mycobacterium tuberculosis • cell death program
View Maziar Divangahi’s recent posts and news below.
2026 RESP Research Day Poster and Oral Winners
Congratulations to all of our oral and poster presenter winners from the 2026 Respiratory Research Day
CIHR Team Grant: Bringing Biology to Cancer Prevention
Congratulations to Dr. Maziar Divangahi and his team on receiving a $2M CIHR team grant to study trained immunity and cancer risk.
CIHR Project Grant Results – Fall 2025
Congratulations to all RESP members who were funded in the Fall 2025 CIHR Project Grant Competition!
β-glucan and Dietary Supplements
Maziar Divangahi discusses his research on β-glucan and lung inflammation with Radio-Canada
Philanthropy Fuels Innovation: 2025 MGH Research Awards
Several RESP Program researchers are among the recipients of the Montreal General Hospital Foundation’s 2025 Research Awards
CIHR Project Grant Results – Spring 2025
Congratulations to all RESP members who were funded in the Spring 2025 CIHR Project Grant Competition!
Trained Immunity May Cause Lung Damage
New study by Maziar Divangahi reveals that trained immunity may worsen lung inflammation during severe inflammation caused by viral or bacterial products
Breakthrough to Boost Bladder Cancer Treatment
Research led by Maziar Divangahi reveals how B-glucan can boost the effectiveness of BCG therapy for bladder cancer
Sustaining Excellence: Supporting Breakthrough Research
Larry Lands, Arnold Kristof, Salman Qureshi, and Maziar Divagnahi receive funding from the Sustaining Excellence Grants Competition.